Relevancy of drug loading to liposomal formulation therapeutic efficacy

Journal of Liposome Research

Volumn 13, Issue 1, 2003, Pages 1-8

  Barenholz, Yechezkel ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIOXIDANT; BUFFER; BUPIVACAINE; CEFTRIAXONE; CIPROFLOXACIN; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; DRUG CARRIER; DRUG VEHICLE; GENTAMICIN; HEPTANE; LIPOSOME; LYCOPENE; MACROGOL 2000; OCTANOL; SODIUM CHLORIDE; TEMPAMINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IONIC STRENGTH; PARTITION COEFFICIENT; PH; PRIORITY JOURNAL;

ANESTHETICS, LOCAL; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HYDROPHOBICITY; LIPOSOMES; SOLUBILITY; THERMODYNAMICS;

EID: 0037231460     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-120017482     Document Type: Conference Paper

References (25)

1. Barenholz Y, Cevc G. Structure and properties of membranes. In: Baszkin A, Norde W., eds. Physical Chemistry of Biological Surfaces. NY: Marcel Dekker, 2000; 171-241.
2. Lasic DD. Liposomes: From Physics to Applications. Amsterdam: Elsevier, 1993.
3. Barenholz Y, Lasic DD, eds. Handbook of Nonmedical Applications of Liposomes. Vols. I-IV. Boca Raton, FL: CRC Press, 1996.
4. Lasic DD. Liposomes in Gene Delivery. Boca Raton, FL: CRC Press, 1997.
5. Barenholz Y, Cohen R. Rational design of amphiphile-based drug carriers and sterically stabilized carriers. J Liposome Res 1995; 5:905-932.
6. Barenholz Y. Design of liposome-based drug carriers: From basic research to application as approved drugs. In: Lasic DD, Papahadjopoulos D, eds. Medical Applications of Liposomes. Amsterdam: Elsevier Science, 1998; 541-565.
7. Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci 2001; 6:66-77.
8. Grant GJ, Barenholz Y, Piskoun B, Bansinath M, Turndorf H, Bolotin E. DRV liposomal bupivacaine: preparation, characterization and in vivo evaluation in mice. Pharm Res 2001; 18:336-343.
9. Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1993;1151:201-215.
10. Stein WD. Transport and Diffusion Across Cell Membranes. Chapter 2. Orlando, FL: Academic Press, 1986.
11. Lasic DD, Ceh B, Stuart MCA, Guo L, Frederik PM, Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochim Biophys Acta 1995; 1239:145-156.
12. Zhang YP, Ceh B, Lasic DD. Liposomes in drug delivery. In: Polymeric Biomaterials. 2nd ed. Chapter 29. Damitziu S, ed. New York: Marcel Dekker, 2001:783-821.
13. Lichtenberg D, Barenholz Y. Liposomes: Preparation, characterization, and preservation. In: Glick D, ed. Methods of Biochemical Analysis. NY: Wiley, 1988; 33:337-462.
14. Bandak S, Goren D, Horowitz A, Tzemach D, Gabizon A. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs 1999; 10:911-920.
15. Kirby C, Gregoriadis G. Dehydration-rehydration in vesicles: A simple method for high yield drug entrapment in liposomes. Biotechnology 1984; 2:979-985.
16. Kedar E, Palgi O, Golod G, Babai I, Barenholz Y. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-α show improved pharmacokinetics and biological activity and reduced toxicity in mice. J Immunother 1997; 20:180-193.
17. Babai I, Samira S, Barenholz Y, Zakai-Rones Z, Kedar E. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine 1999; 17:1223-1238.
18. Babai I, Samira S, Barenholz Y, Zakai-Rones Z, Kedar E. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/ neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. Vaccine 1999b; 17:1239-1250.
19. Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M, Kedar E. A novel liposomal influenza vaccine (INFLUSOMEVAC) containing haemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains. Vaccine 2001; 12:505-515.
20. Barenholz Y, Crommelin DJA. Liposomes as pharmaceutical dosage forms. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Vol. 9. NY: Marcel Dekker, 1994:1-39.
21. Szoka F Jr, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 75:4194-4198.
22. Peleg-Shulman T, Gibson D, Cohen R, Abra R, Barenholz Y. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. Biochim Biophys Acta 2001; 1510:278-291.
23. Gabizon A, Barenholz Y. Liposomal anthracyclines - from basics to clinical approval of PEGylated liposomal doxorubicin. In: Janoff AS, ed. Liposomes: Rational Design. NY: Marcel Dekker, 1999:343-362.
24. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54:987-992.
25. Gabizon A, Goren D, Cohen R, Barenholz Y. Development of liposomal anthracyclines: from basics to clinical applications. J Controlled Release 1998; 53:275-279.